Alisa Lask is Director of RVL Pharmaceuticals plc. Currently has a direct ownership of 112,557 shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on Aug 10, 2023, when has been sold 12,000 shares (Ordinary Shares) at a price of $0.49 per share, resulting in proceeds of $5,880. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 113K
0% 3M change
0% 12M change
Total Value Held $0

Alisa Lask Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 10 2023
SELL
Payment of exercise price or tax liability
$5,880 $0.49 p/Share
12,000 Reduced 9.63%
112,557 Ordinary Shares
Jul 05 2023
BUY
Grant, award, or other acquisition
-
40,000 Added 24.31%
124,557 Ordinary Shares
Aug 10 2022
BUY
Grant, award, or other acquisition
-
75,000 Added 47.01%
84,557 Ordinary Shares

Also insider at

NEPH
NEPHROS INC Healthcare
AL

Alisa Lask

Director
Bridgewater, NJ

Track Institutional and Insider Activities on RVLP

Follow RVL Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

News

Receive news related to RVL Pharmaceuticals plc

Track Activities on RVLP